Medical School
- MD, Drexel University College of Medicine (2003)
Graduate School
- MS, University of Pennsylvania (2018)
Undergraduate School
- BS, University of California–Davis (CA) (1999)
Residency
- Thomas Jefferson University Program, Internal Medicine (2009)
Fellowships
- Hospital of the University of Pennsylvania, Pulmonary Disease and Critical Care Medicine (2012)
Languages
EnglishDepartment
Medicine-Pulmonary Sciences & Critical CareProfessional Titles
- Director of Interventional Pulmonology
Publications
- Zhang C, Kim RY, McGrath CM, Andronov M, Haas AR, Ma KC, Lanfranco AR, Hutchinson CT, Morrissette JJD, DiBardino DM. The Performance of an Extended Next Generation Sequencing Panel Using Endobronchial Ultrasound-Guided Fine Needle Aspiration Samples in Non-Squamous Non-Small Cell Lung Cancer: A Pragmatic Study. Clin Lung Cancer. 2023 Mar;24(2):e105-e112. PubMed PMID: 36599742
- Reese ZA, Lanfranco A, Khafateh Y, Heath JK. Following the Brick Road: A Woman with Dyspnea, Hypoxemia, and Ground-Glass Opacities with Septal Thickening on Thoracic Imaging. Ann Am Thorac Soc. 2022 May;19(5):845-849. PubMed PMID: 35486081
- DiBardino DM, Andronov M, Haas AR, Lanfranco AR, Ma KC. Utility and Safety of Airway Stenting in Distal Airways Stenosis After Lung Transplant. J Bronchology Interv Pulmonol. 2020 Oct;27(4):274-279. PubMed PMID: 32217948
- Ma KC, Li M, Haas AR, Lanfranco AR, Moon EK, DiBardino DM. Efficacy and safety of airway stenting to treat anastomotic complications after lung transplant: a cohort study. J Thorac Dis. 2020 Jul;12(7):3539-3548. PubMed PMID: 32802433
- Chick JFB, Nadolski GJ, Lanfranco AR, Haas A, Itkin M. Dynamic Contrast-Enhanced Magnetic Resonance Lymphangiography and Percutaneous Lymphatic Embolization for the Diagnosis and Treatment of Recurrent Chyloptysis. J Vasc Interv Radiol. 2019 Jul;30(7):1135-1139. PubMed PMID: 30093214
- DiBardino DM, Lanfranco AR, Haas AR, Itkin M. Blue Bronchoscopy: Confirmation of Aberrant Pulmonary Lymphatic Perfusion During Lymphangiography. J Bronchology Interv Pulmonol. 2017 Oct;24(4):e51-e52. PubMed PMID: 28957894
- DiBardino DM, Haas AR, Lanfranco AR, Litzky LA, Sterman D, Bessich JL. High Complication Rate after Introduction of Transbronchial Cryobiopsy into Clinical Practice at an Academic Medical Center. Ann Am Thorac Soc. 2017 Jun;14(6):851-857. PubMed PMID: 28231021
- DiBardino DM, Haas AR, Lanfranco AR, Litzky LA, Sterman D, Bessich JL. Reply: Careful Planning Reduces Cryobiopsy Complications. Ann Am Thorac Soc. 2017 Jul;14(7):1230. PubMed PMID: 28665703
- DiBardino DM, Lanfranco AR, Haas AR, Litzky LA, Sterman D, Bessich JL. Reply: A Cautionary Tale and Opportunities for Improvement in Transbronchial Cryobiopsy. Ann Am Thorac Soc. 2017 Jul;14(7):1231-1232. PubMed PMID: 28665699
- DiBardino DM, Lanfranco AR, Haas AR. Bronchoscopic Cryotherapy. Clinical Applications of the Cryoprobe, Cryospray, and Cryoadhesion. Ann Am Thorac Soc. 2016 Aug;13(8):1405-15. PubMed PMID: 27268274
- Goudra BG, Singh PM, Manjunath AK, Reihmer JW, Haas AR, Lanfranco AR, Sinha AC, Harris K. Effectiveness of high dose remifentanil in preventing coughing and laryngospasm in non-paralyzed patients for advanced bronchoscopic procedures. Ann Thorac Med. 2014 Jan;9(1):23-8. PubMed PMID: 24551014
- Chemnitz JM, Lanfranco AR, Braunstein I, Riley JL. B and T lymphocyte attenuator-mediated signal transduction provides a potent inhibitory signal to primary human CD4 T cells that can be initiated by multiple phosphotyrosine motifs. J Immunol. 2006 Jun 1;176(11):6603-14. PubMed PMID: 16709818
- Parry RV, Chemnitz JM, Frauwirth KA, Lanfranco AR, Braunstein I, Kobayashi SV, Linsley PS, Thompson CB, Riley JL. CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms. Mol Cell Biol. 2005 Nov;25(21):9543-53. PubMed PMID: 16227604
- Lanfranco AR, Castellanos AE, Desai JP, Meyers WC. Robotic surgery: a current perspective. Ann Surg. 2004 Jan;239(1):14-21. PubMed PMID: 14685095
Practice Locations
UCHealth University of Colorado Hospital (UCH)12605 E. 16th Ave
Aurora, CO 80045
720-848-0000
Hospital Affiliation
- University of Colorado Hospital
- UCHealth Highlands Ranch Hospital
Specialty Information
Specialties- Pulmonary Disease and Critical Care Medicine
- Interventional Pulmonology, Board Certification (2012)
- Lungs and Breathing - Interventional Pulmonology
- Lungs and Breathing
- Cancers - Lung Cancer
- Cancers
- Cancers - Thoracic (Tracheal, Esophageal)
Clinical Interests
My clinical interests in interventional pulmonology focus on the comprehensive evaluation and management of pulmonary nodules and thoracic malignancies using advanced diagnostic bronchoscopy, including robotic-assisted platforms, endobronchial ultrasound, and navigational techniques. I have a strong interest in therapeutic bronchoscopy for central airway obstruction, utilizing tumor debulking, airway stenting, and ablative modalities to restore airway patency and improve symptoms. My practice also emphasizes the management of pleural disease through indwelling pleural catheters, medical thoracoscopy, and pleurodesis, as well as bronchoscopic lung volume reduction for patients with advanced emphysema. Additional clinical interests include transbronchial cryobiopsy for diffuse parenchymal lung disease, the management of complex airway disorders such as tracheal stenosis and tracheobronchomalacia, and the application of interventional techniques in critically ill patients, including airway management, percutaneous tracheostomy, and the evaluation and treatment of hemoptysis.
Care Philosophy
My approach to patient care is grounded in thoughtful, patient-centered decision-making that prioritizes doing the right intervention for the right patient at the right time. In interventional pulmonology, the goal is not simply to perform procedures, but to use minimally invasive techniques in a way that meaningfully improves diagnosis, symptoms, and quality of life. I emphasize careful integration of clinical context, imaging, and procedural options to guide management—particularly in patients with pulmonary nodules, thoracic malignancies, airway disease, and pleural disorders. Whenever possible, I aim to provide efficient, streamlined care that reduces time to diagnosis and treatment while minimizing unnecessary interventions and risk. Care is delivered within a multidisciplinary framework, recognizing that optimal outcomes in pulmonary and thoracic disease depend on close collaboration with oncology, thoracic surgery, radiology, and critical care. Equally important is clear communication with patients and referring providers, ensuring that care plans are aligned with patient goals and that continuity is maintained across the episode of care. Ultimately, my goal is to deliver precise, evidence-informed, and compassionate care—using interventional techniques not as an end in themselves, but as tools to improve the lives of the patients we serve.
My clinical interests in interventional pulmonology focus on the comprehensive evaluation and management of pulmonary nodules and thoracic malignancies using advanced diagnostic bronchoscopy, including robotic-assisted platforms, endobronchial ultrasound, and navigational techniques. I have a strong interest in therapeutic bronchoscopy for central airway obstruction, utilizing tumor debulking, airway stenting, and ablative modalities to restore airway patency and improve symptoms. My practice also emphasizes the management of pleural disease through indwelling pleural catheters, medical thoracoscopy, and pleurodesis, as well as bronchoscopic lung volume reduction for patients with advanced emphysema. Additional clinical interests include transbronchial cryobiopsy for diffuse parenchymal lung disease, the management of complex airway disorders such as tracheal stenosis and tracheobronchomalacia, and the application of interventional techniques in critically ill patients, including airway management, percutaneous tracheostomy, and the evaluation and treatment of hemoptysis.
Care Philosophy
My approach to patient care is grounded in thoughtful, patient-centered decision-making that prioritizes doing the right intervention for the right patient at the right time. In interventional pulmonology, the goal is not simply to perform procedures, but to use minimally invasive techniques in a way that meaningfully improves diagnosis, symptoms, and quality of life. I emphasize careful integration of clinical context, imaging, and procedural options to guide management—particularly in patients with pulmonary nodules, thoracic malignancies, airway disease, and pleural disorders. Whenever possible, I aim to provide efficient, streamlined care that reduces time to diagnosis and treatment while minimizing unnecessary interventions and risk. Care is delivered within a multidisciplinary framework, recognizing that optimal outcomes in pulmonary and thoracic disease depend on close collaboration with oncology, thoracic surgery, radiology, and critical care. Equally important is clear communication with patients and referring providers, ensuring that care plans are aligned with patient goals and that continuity is maintained across the episode of care. Ultimately, my goal is to deliver precise, evidence-informed, and compassionate care—using interventional techniques not as an end in themselves, but as tools to improve the lives of the patients we serve.